Intervention Review

You have free access to this content

Mannitol for acute traumatic brain injury

  1. Abel Wakai1,*,
  2. Ian G Roberts2,
  3. Gillian Schierhout3

Editorial Group: Cochrane Injuries Group

Published Online: 8 OCT 2008

Assessed as up-to-date: 28 FEB 2006

DOI: 10.1002/14651858.CD001049.pub4

Database Title

Additional Information

How to Cite

Wakai A, Roberts IG, Schierhout G. Mannitol for acute traumatic brain injury. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD001049. DOI: 10.1002/14651858.CD001049.pub4.

Author Information

  1. 1

    Sunnybrook Health Sciences Centre, Division of Emergency Medicine, Toronto, Ontario, Canada

  2. 2

    London School of Hygiene & Tropical Medicine, Cochrane Injuries Group, London, UK

  3. 3

    London School of Hygiene & Tropical Medicine, c/o Cochrane Injuries Group, London, UK

*Abel Wakai, Division of Emergency Medicine, Sunnybrook Health Sciences Centre, Suite C7-16, Toronto, Ontario, M4N 3M5, Canada. abelwakai@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 OCT 2008

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (57K)Standard (151K)Full (173K)
[Analysis 1.1]
Analysis 1.1. Comparison 1 ICP-directed mannitol ('treatment') compared to mannitol according to neurological signs ('control'), Outcome 1 Death.
[Analysis 1.2]
Analysis 1.2. Comparison 1 ICP-directed mannitol ('treatment') compared to mannitol according to neurological signs ('control'), Outcome 2 Death or severe disability.
[Analysis 2.1]
Analysis 2.1. Comparison 2 Mannitol versus pentobarbital, Outcome 1 Death.
[Analysis 3.1]
Analysis 3.1. Comparison 3 Mannitol versus hypertonic saline, Outcome 1 Death.
[Analysis 4.1]
Analysis 4.1. Comparison 4 Mannitol versus placebo, Outcome 1 Death.
View Full Article (HTML) Summary (57K)Standard (151K)Full (173K)